Just a moment, the page is loading...
Login
My Submissions
Postings
Create Account
My Awards
♥
Grants and Funding
At Immunocore, we want to radically improve outcomes for patients with cancer, infectious diseases, and autoimmune diseases, by pioneering and delivering transformative immunomodulating medicine.
We recognize that medical science evolves rapidly with new information becoming available constantly. As part of the healthcare system, we also understand the need to support healthcare professionals in their pursuit of research activities and the most current education to provide the best patient care possible. There is further need to support patients, caregivers and communities to ensure that they have the information and medicines or treatments to support healthy, quality, and productive lives.
As such, we are proud to have the opportunity to consider funding applications for:
View All Selected
Clear All
Uveal Melanoma: Rational combinations addressing mechanisms for overcoming resistance (primary and/or secondary) to Tebentafusp or enhancing Tebentafusp activity in 1L metastatic disease
Area of Interest Details
Products:
Tebentafusp
Open for Submissions:
1 May 2025
Deadline for Submissions (by 23:59 UTC):
13 June 2025
Applicants will be notified by:
4 Aug 2025
To help us verify your identity, a validation code will be sent to you.
Phone Number (By providing your phone number, you agree to receive text messages. Message and data rates may apply.) Please add country code.
Email Address (Code will be sent via email. If you don't see the email in your inbox, please check your spam folder.)
Enter code here
Privacy
MM-UK--2500001
Date of production: March 2025